Ginkgo Bioworks (NYSE:DNA) Stock Price Up 8.8% – Here’s What Happened

Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) traded up 8.8% during mid-day trading on Friday . The stock traded as high as $14.58 and last traded at $14.74. 625,008 shares changed hands during trading, a decline of 59% from the average session volume of 1,532,414 shares. The stock had previously closed at $13.55.

Ginkgo Bioworks Price Performance

The firm has a market capitalization of $861.97 million, a P/E ratio of -1.15 and a beta of 1.16. The company’s 50-day moving average is $11.12.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in DNA. Price T Rowe Associates Inc. MD increased its position in shares of Ginkgo Bioworks by 4.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 82,815 shares of the company’s stock worth $814,000 after purchasing an additional 3,152 shares during the last quarter. Marshall Wace LLP bought a new position in shares of Ginkgo Bioworks during the fourth quarter worth about $665,000. Jump Financial LLC acquired a new position in Ginkgo Bioworks in the fourth quarter worth about $505,000. Barclays PLC increased its holdings in Ginkgo Bioworks by 353.6% in the fourth quarter. Barclays PLC now owns 54,166 shares of the company’s stock valued at $531,000 after buying an additional 42,224 shares during the last quarter. Finally, Renaissance Technologies LLC raised its stake in Ginkgo Bioworks by 65.1% during the fourth quarter. Renaissance Technologies LLC now owns 114,654 shares of the company’s stock valued at $1,126,000 after buying an additional 45,200 shares in the last quarter. 78.63% of the stock is currently owned by institutional investors.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.